|
ATP11B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.202400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.419800E-01 |
| Normal-vs-Stage2 |
6.324400E-01 |
| Normal-vs-Stage3 |
4.405800E-02 |
| Normal-vs-Stage4 |
4.462500E-02 |
| Stage1-vs-Stage2 |
8.451400E-01 |
| Stage1-vs-Stage3 |
3.326100E-02 |
| Stage1-vs-Stage4 |
6.142200E-02 |
| Stage2-vs-Stage3 |
3.052600E-01 |
| Stage2-vs-Stage4 |
3.241200E-01 |
| Stage3-vs-Stage4 |
9.634400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.239400E-01 |
| Normal-vs-AfricanAmerican |
7.221200E-03 |
| Normal-vs-Asian |
7.008400E-01 |
| Caucasian-vs-AfricanAmerican |
1.487980E-02 |
| Caucasian-vs-Asian |
4.817000E-01 |
| AfricanAmerican-vs-Asian |
8.346300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.582500E-02 |
| Normal-vs-Female |
9.373200E-01 |
| Male-vs-Female |
1.523650E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.777600E-01 |
| Normal-vs-Age(41-60Yrs) |
6.861000E-01 |
| Normal-vs-Age(61-80Yrs) |
4.835600E-02 |
| Normal-vs-Age(81-100Yrs) |
6.190200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.637000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.510200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.452400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.093700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.345800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.898200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.896750E-01 |
| Normal-vs-Grade 2 |
8.866600E-01 |
| Normal-vs-Grade 3 |
1.714200E-02 |
| Normal-vs-Grade 4 |
1.156210E-02 |
| Grade 1-vs-Grade 2 |
3.030200E-01 |
| Grade 1-vs-Grade 3 |
6.479900E-03 |
| Grade 1-vs-Grade 4 |
8.000300E-03 |
| Grade 2-vs-Grade 3 |
2.043500E-03 |
| Grade 2-vs-Grade 4 |
2.456300E-03 |
| Grade 3-vs-Grade 4 |
3.202200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.737800E-01 |
| Normal-vs-ccB subtype |
4.278000E-02 |
| ccA subtype-vs-ccB subtype |
2.023100E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.857000E-01 |
| Normal-vs-N1 |
2.246000E-01 |
| N0-vs-N1 |
4.093400E-01 |
|
|
